Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis

Akira Hanazono, Keita Yasuda, Hinako Shimada, Yui Sanpei

Open source

DOI
10.1016/j.msard.2026.107889
Published
2026-11
Container
Multiple Sclerosis and Related Disorders
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.msard.2026.107889,
  title = {Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis},
  author = {Akira Hanazono and Keita Yasuda and Hinako Shimada and Yui Sanpei},
  year = {2026},
  journal = {Multiple Sclerosis and Related Disorders},
  doi = {10.1016/j.msard.2026.107889},
  url = {https://doi.org/10.1016/j.msard.2026.107889}
}

RIS

TY  - JOUR
TI  - Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis
AU  - Akira Hanazono
AU  - Keita Yasuda
AU  - Hinako Shimada
AU  - Yui Sanpei
PY  - 2026
JO  - Multiple Sclerosis and Related Disorders
DO  - 10.1016/j.msard.2026.107889
UR  - https://doi.org/10.1016/j.msard.2026.107889
ER  - 

APA

Hanazono, A., Yasuda, K., Shimada, H., & Sanpei, Y. (2026). Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2026.107889

Source records